Description
The Sofia SARS Antigen Fluorescent Immunoassay (FIA) uses advanced immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from SARS-CoV-2. The Sofia SARS Antigen FIA, with the Sofia 2 and Sofia analyzers, provides automated and objective results in 15 minutes, allowing for testing of patients suspected of COVID-19/2019-nCoV in near-patient testing environments.
Healthcare professionals can purchase the Sofia SARS Antigen FIA through select authorized distributors.
Features
| Results in 15 minutes | Rapid results to support efficient dispositioning of patients. |
| Objective, accurate results | Reliable results without cross-reactivity to seasonal coronaviruses. |
| Dual work modes | Adjusts to your volume fluctuations. Allows for significant throughput and batching of samples in READ NOW Mode. |
| Easy to use | Simple test workflow follows a similar format to CLIA-waived Sofia and Sofia 2 assays. |
| Virena connection | Provides automated tracking, data capture, government reporting, and exclusive disease mapping. |
| Fluorescent technology with automated read | Objective result that eliminates the subjectivity of a visual read. |
| All necessary components included in kit | Ready for use with Sofia 2 and Sofia for nasal swab procedure. |
| Self-contained Test Cassette | Clean, easy to use and dispose of. |
*Information taken from Quidel Website
